FDA Drug Application (017812) for LITHIUM CARBONATE by ROXANE

Back to FDA Applications sponsored by ROXANE

Application Number017812
Product Number001
FormCAPSULE;ORAL
Dosage300MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameLITHIUM CARBONATE
Active IngredientLITHIUM CARBONATE

Active IngredientCount
List of drugs with Active Ingredient LITHIUM CARBONATE7


Back to FDA Applications sponsored by ROXANE